Avanos Medical [AVNS] vs Stryker [SYK] Detailed Stock Comparison

Avanos Medical Inc.

NYSE
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Avanos Medical Inc. wins in 6 metrics, Stryker Corporation wins in 14 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Avanos Medical Inc. Stryker Corporation Better
P/E Ratio (TTM) 34.37 39.21 Avanos Medical Inc.
Price-to-Book Ratio 1.47 5.62 Avanos Medical Inc.
Debt-to-Equity Ratio 16.59 72.97 Avanos Medical Inc.
PEG Ratio -0.34 0.72 Stryker Corporation
EV/EBITDA 21.79 19.90 Stryker Corporation
Profit Margin (TTM) -10.40% 12.92% Stryker Corporation
Operating Margin (TTM) 1.99% 27.24% Stryker Corporation
EBITDA Margin (TTM) 1.99% 27.24% Stryker Corporation
Return on Equity -9.08% 15.08% Stryker Corporation
Return on Assets (TTM) 0.87% 7.92% Stryker Corporation
Free Cash Flow (TTM) $43.10M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return 106.28% -17.25% Avanos Medical Inc.
Price-to-Sales Ratio (TTM) 1.64 5.02 Avanos Medical Inc.
Enterprise Value $1.19B $138.30B Stryker Corporation
EV/Revenue Ratio 1.69 5.51 Avanos Medical Inc.
Gross Profit Margin (TTM) 47.54% 64.54% Stryker Corporation
Revenue per Share (TTM) $15 $66 Stryker Corporation
Earnings per Share (Diluted) $-1.57 $8.40 Stryker Corporation
Beta (Stock Volatility) 1.05 0.93 Stryker Corporation
Short % of Float 6.25% 1.20% Stryker Corporation

Avanos Medical Inc. vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

AVNS
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Avanos Medical Inc.0.00%-0.16%1.01%80.61%110.46%123.26%
Stryker Corporation-1.36%2.13%0.38%-11.91%-13.33%-11.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Avanos Medical Inc.106.28%-2.50%-37.21%-22.48%-35.57%-35.57%
Stryker Corporation-17.25%6.06%22.47%172.95%440.98%592.85%

Performance & Financial Health Analysis: Avanos Medical Inc. vs Stryker Corporation

MetricAVNSSYK
Market Information
Market Cap i$1.15B$126.25B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i3,796,9241,881,406
90 Day Avg. Volume i1,631,7982,161,139
Last Close$24.96$307.94
52 Week Range$9.30 - $25.49$281.00 - $404.87
% from 52W High-2.08%-23.94%
All-Time High$72.96 (Sep 03, 2018)$406.19 (Jan 27, 2025)
% from All-Time High-65.79%-24.19%
Growth Metrics
Quarterly Revenue Growth0.01%0.11%
Quarterly Earnings Growth0.01%0.56%
Financial Health
Profit Margin (TTM) i-0.10%0.13%
Operating Margin (TTM) i0.02%0.27%
Return on Equity (TTM) i-0.09%0.15%
Debt to Equity (MRQ) i16.5972.97
Cash & Liquidity
Book Value per Share (MRQ)$16.75$58.61
Cash per Share (MRQ)$1.93$10.71
Operating Cash Flow (TTM) i$74.70M$5.04B
Levered Free Cash Flow (TTM) i$46.01M$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: Avanos Medical Inc. vs Stryker Corporation

MetricAVNS (Apr 24, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i34.3739.21
Forward P/E i19.7119.67
PEG Ratio i-0.340.72
Price to Sales (TTM) i1.645.02
Price to Book (MRQ) i1.475.62
Market Capitalization
Market Capitalization i$1.15B$126.25B
Enterprise Value i$1.19B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i1.695.51
Enterprise to EBITDA i21.7919.90
Risk & Other Metrics
Beta i1.050.93
Book Value per Share (MRQ) i$16.75$58.61

Financial Statements Comparison: Avanos Medical Inc. vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAVNS (2025)SYK (2025)
Revenue/Sales i701.20M25.12B
Cost of Goods Sold i347.30M9.05B
COGS % of Revenue i49.5%36.0%
Gross Profit i353.90M16.07B
Gross Margin i50.5%64.0%
Research & Development i23.30M1.62B
Operating Income (EBIT) i15.40M5.06B
Operating Margin i2.2%20.1%
EBITDA i57.50M6.48B
EBITDA Margin i8.2%25.8%
Pre-Tax Income i-66.20M4.51B
Pre-Tax Income % of Revenue i-9.4%18.0%
Income Tax i6.70M1.27B
Income Tax % of Revenue i1.0%5.0%
Net Income (Profit) i-72.90M3.25B
Profit Margin i-10.4%12.9%

Balance Sheet & Liquidity Metrics

MetricAVNS (2025)SYK (2025)
Cash & Equivalents i89.80M4.01B
Total Current Assets i355.40M14.76B
Total Current Assets % of Revenue i50.7%58.7%
Total Current Liabilities i165.20M7.79B
Total Current Liabilities % of Revenue i23.6%31.0%
Long-Term Debt i110.70M14.86B
Long-Term Debt % of Revenue i15.8%59.2%
Total Shareholders Equity i778.20M22.42B
Retained Earnings i-779.90M20.47B
Retained Earnings % of Revenue i-111.2%81.5%
Property, Plant & Equipment i27.60M1.79B

Cash Flow Statement Comparison

MetricAVNS (2025)SYK (2025)
Operating Cash Flow i10.30M4.70B
Operating Cash Flow % of Revenue i1.5%18.7%
Capital Expenditures iN/A-761.00M
Free Cash Flow i43.10M4.28B
FCF Margin i6.1%17.1%
Debt Repayment i-34.40M-1.40B
Common Stock Repurchase i-3.30MN/A

Short Interest & Institutional Ownership Analysis

MetricAVNSSYK
Shares Short i2.17M4.42M
Short Ratio i3.751.95
Short % of Float i6.25%1.20%
Shares Outstanding i46.46M382.50M
Float Shares i42.02M346.55M
% Held by Insiders i4.79%5.37%
% Held by Institutions i98.76%82.09%
% Held by Public i-3.55%12.54%

Dividend Analysis & Yield Comparison: Avanos Medical Inc. vs Stryker Corporation

MetricAVNSSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025